118 related articles for article (PubMed ID: 38113962)
1. Fas
Bohat R; Liang X; Chen Y; Xu C; Zheng N; Guerrero A; Hou J; Jaffery R; Egan NA; Li Y; Tang Y; Unsal E; Robles A; Chen S; Major AM; Elldakli H; Chung SH; Liang H; Hicks MJ; Du Y; Lin JS; Chen X; Mohan C; Peng W
Clin Immunol; 2024 Jan; 258():109874. PubMed ID: 38113962
[TBL] [Abstract][Full Text] [Related]
2. Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity.
Shi X; Xie C; Kreska D; Richardson JA; Mohan C
J Exp Med; 2002 Aug; 196(3):281-92. PubMed ID: 12163557
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
[TBL] [Abstract][Full Text] [Related]
4. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
Ashman RF; Singh N; Lenert PS
Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
[TBL] [Abstract][Full Text] [Related]
5. Genetic dissection of systemic lupus erythematosus pathogenesis: partial functional complementation between Sle1 and Sle3/5 demonstrates requirement for intracellular coexpression for full phenotypic expression of lupus.
Wakui M; Morel L; Butfiloski EJ; Kim C; Sobel ES
J Immunol; 2005 Jul; 175(2):1337-45. PubMed ID: 16002739
[TBL] [Abstract][Full Text] [Related]
6. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease.
Cauwe B; Martens E; Sagaert X; Dillen C; Geurts N; Li S; Mertens J; Thijs G; Van den Steen PE; Heremans H; De Vos R; Blockmans D; Arnold B; Opdenakker G
J Autoimmun; 2011 May; 36(3-4):239-52. PubMed ID: 21376533
[TBL] [Abstract][Full Text] [Related]
8.
Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
[TBL] [Abstract][Full Text] [Related]
9. IL-10 regulates murine lupus.
Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
[TBL] [Abstract][Full Text] [Related]
10. The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression.
Kong PL; Morel L; Croker BP; Craft J
J Immunol; 2004 Mar; 172(5):2785-94. PubMed ID: 14978078
[TBL] [Abstract][Full Text] [Related]
11. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
12. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice.
Corneth OBJ; Schaper F; Luk F; Asmawidjaja PS; Mus AMC; Horst G; Heeringa P; Hendriks RW; Westra J; Lubberts E
Sci Rep; 2019 Mar; 9(1):4032. PubMed ID: 30858513
[TBL] [Abstract][Full Text] [Related]
13. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
Yajima K; Nakamura A; Sugahara A; Takai T
Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
[TBL] [Abstract][Full Text] [Related]
14. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
[TBL] [Abstract][Full Text] [Related]
15. A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice.
Komori H; Furukawa H; Mori S; Ito MR; Terada M; Zhang MC; Ishii N; Sakuma N; Nose M; Ono M
J Immunol; 2006 Jan; 176(1):395-400. PubMed ID: 16365433
[TBL] [Abstract][Full Text] [Related]
16. The major murine systemic lupus erythematosus susceptibility locus Sle1 results in abnormal functions of both B and T cells.
Sobel ES; Satoh M; Chen Y; Wakeland EK; Morel L
J Immunol; 2002 Sep; 169(5):2694-700. PubMed ID: 12193743
[TBL] [Abstract][Full Text] [Related]
17. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
[TBL] [Abstract][Full Text] [Related]
18. P2X7 purinergic receptor plays a critical role in maintaining T-cell homeostasis and preventing lupus pathogenesis.
Mellouk A; Hutteau-Hamel T; Legrand J; Safya H; Benbijja M; Mercier-Nomé F; Benihoud K; Kanellopoulos JM; Bobé P
Front Immunol; 2022; 13():957008. PubMed ID: 36248812
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of stem cell antigen-1 (Ly-6A/E) in lymphocytes from lupus prone mice correlates with disease severity.
Kumar KR; Zhu J; Bhaskarabhatla M; Yan M; Mohan C
J Autoimmun; 2005 Nov; 25(3):215-22. PubMed ID: 16246522
[TBL] [Abstract][Full Text] [Related]
20. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
